FDA debuts new online portal to encourage donation of plasma from recovered COVID-19 patients
One of the avenues currently being pursued in terms of developing an effective treatment for COVID-19 is through the use of convalescent plasma. Basically, that means using the liquid component of blood from people who have had, and already recovered fully from, COVID-19 to produce treatments that hopefully translate to others the antibodies they developed … Continue reading FDA debuts new online portal to encourage donation of plasma from recovered COVID-19 patients Continue Reading

